↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$3.1MSold on the market
1Companies
Oct 7, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202617:11 | Oct 5, 2026 | FDMT4D Molecular Therapeutics, Inc. | See Remarks, Director | S · Sell10b5-1 | $12.92 | −58,333 | 709,153 | -8% | −$754K | ||
| Sep 16, 202617:13 | Sep 14, 2026 | FDMT4D Molecular Therapeutics, Inc. | See Remarks, Director | S · Sell10b5-1 | $13.90 | −58,333 | 767,486 | -7% | −$811K | ||
| Aug 21, 202616:06 | Aug 19, 2026 | FDMT4D Molecular Therapeutics, Inc. | See Remarks, Director | S · Sell10b5-1 | $15.75 | −69,076 | 825,819 | -8% | −$1.1M | ||
| Aug 21, 202616:06 | Aug 19, 2026 | FDMT4D Molecular Therapeutics, Inc. | See Remarks, Director | M · Exercise10b5-1 | $4.14 | +50,000 | 894,895 | +6% | $207K | ||
| Aug 5, 202616:10 | Aug 4, 2026 | FDMT4D Molecular Therapeutics, Inc. | See Remarks, Director | S · Sell10b5-1 | $10.23 | −26,842 | 844,895 | -3% | −$275K | ||
| Aug 4, 202616:45 | Aug 3, 2026 | FDMT4D Molecular Therapeutics, Inc. | See Remarks, Director | S · Sell10b5-1 | $10.05 | −12,415 | 871,737 | -1% | −$125K |